Video

Exploring gut microbiota in Autism Spectrum Disorder: a metagenomic case study comparing an ASD patient with an at-risk infant sibling

Microbiomepost conducted an exclusive interview with Martina Piacente, from Ebris - European Biomedical Research Institute of Salerno, about the role of gut microbiome in Autism Spectrum Disorder.

Exploring the connection between the microbiome and musculoskeletal performance

Microbiomepost conducted an exclusive interview with Antonio Paoli, full professor of Sport and Exercise Sciences at University of Padua, in Italy, about how exercise interferes with gut microbiome.

Boosting poultry resilience with Bacillus subtilis DSM29784 metabolites

Microbiomepost conducted an exclusive interview with Nuria Vieco, Adisseo France S.A.S, European Laboratory of Innovation Science and Expertise ELISE, about the effect of Bacillus subtilis DSM29784 secreted metabolites on poultry…

Next-Level microbiome analysis: the synergy of FISH and dPCR techniques

Microbiomepost conducted an exclusive interview with Jiri Snaidr, Founder and CEO at Vermicon AG, about the possibility to combine Fluorescence In Situ Hybridization (FISH) and Digital PCR (dPCR) for advanced…

Fermented Beetroot alters gut microbiota and prevents prediabetes in high-fat-fed mice 

Microbiomepost conducted an exclusive interview with Eric Daliri, from Vilnius University, about the possibility of prevent diabetes modulating gut microbiome.

Exploring the critical role of soil microbiome in sustaining civilization

Microbiomepost conducted an exclusive interview with Nina Vinot, Bioprox Healthcare, about the new frontiers of the microbiome revolution: the role of soil microbiome in the agriculture space.

Alessio Fasano – 10th International Human Microbiome Consortium (IHMC) Congress 2024 key highlights

Alessio Fasano, Chair of the Congress, shares an overview of the event and the future challenges.

George Paraskevakos at IPC 2024: trends and future challenges in the Biotic market

During IPC 2024, George Paraskevakos shared recent updates on market developments and an overview of the Biotic-related survey.

Miquel Bonachera discusses AB-BIOTICS’ new role on the IPA Board of Directors

AB-Biotics recently appointed to the IPA board of directors. What opportunities and future developments? We discussed this with Miquel Bonachera.

The new frontier: polyclonal antibodies in microbiome editing

Satish Chandran, President and Chief Executive Officer at Prodigy Biotech, Inc., details the company's program aimed at treating alcoholic liver disease, spotlighting Enterococcus faecalis as the primary antagonist.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top